Thus KLF5 and STAT3 signaling provide important areas for further study in colitis and represent potential diagnostic and therapeutic targets for IBD and other diseases characterized by injury and disruption of intestinal epithelia. This evidence concerns the gene KLF5 and inflammatory bowel disease.